In the BioHarmony Drug Report Database

"Preview" Icon

Fluphenazine

Permitil, Prolixin (fluphenazine) is a small molecule pharmaceutical. Fluphenazine was first approved as Permitil on 1982-01-01. It is used to treat psychotic disorders and schizophrenia in the USA. The pharmaceutical is active against D(2) dopamine receptor. In addition, it is known to target D(1A) dopamine receptor, 5-hydroxytryptamine receptor 6, 5-hydroxytryptamine receptor 7, D(1B) dopamine receptor, 5-hydroxytryptamine receptor 2A, and histamine H1 receptor.

 

Trade Name

 

Permitil, Prolixin
 

Common Name

 

fluphenazine
 

ChEMBL ID

 

CHEMBL726
 

Indication

 

psychotic disorders, schizophrenia
 

Drug Class

 

Typical antipsychotic

Image (chem structure or protein)

Fluphenazine structure rendering